About this episode
Our guest on the podcast today is Howard Gleckman. He is the author of a book called Caring for Our Parents and an expert on the topic of aging and caregiving. Howard is also a senior fellow at the Urban Institute where he is affiliated with the Tax Policy Center and the Program on Retirement Policy. He also writes a tax and budget policy blog called TaxVox , which is available at Forbes.com . Before joining the Urban Institute, he was a senior correspondent in the Washington Bureau of Businessweek . Background Bio Urban Institute TaxVox blog Caring For Our Parents , by Howard Gleckman Long-Term Care and Cognitive Decline “ Is Long-Term Care a Predictable Need, or an Unexpected One? ” by Howard Gleckman, Forbes.com , April 15, 2022. “ The U.S. Needs to Help Seniors and Their Families Navigate Long-Term Care ,” by Howard Gleckman, Forbes.com , Oct. 11, 2022. “ The Quiet Struggles With Those Living Alone With Memory Loss ,” by Howard Gleckman, Forbes.com , July 18, 2023. “ Which States Provide the Best—and Worst—Long-Term Care Services? ” by Howard Gleckman, howardgleckman.com , Oct. 2, 2023. “ Why Are Care Delivery Models for People With Dementia Developing so Slowly? ” by Howard Gleckman, howardgleckman.com , June 27, 2023. “ FDA Has Approved the Anti-Alzheimer’s Drug, Leqembi. What You Need to Know ,” by Howard Gleckman, howardgleckman.com , July 6, 2023. “ Experts Raise Questions About the Safety of Anti-Alzheimer’s Drug Leqembi ,” by Howard Gleckman, howardgleckman.com , April 25, 2023. “ Aging in Place Is all the Rage, But It’s Not Easy ,” by Howard Gleckman, Forbes.com , March 21, 2022. Cost of Care “ Medicaid Will Pay for a Common Alzheimer’s Test But It May Not Be Reliable ,” by Howard Gleckman, howardgleckman.com , Jan. 9, 2024. “ Why Medicare Is Right to Negotiate Drug Prices ,” by Howard Gleckman, howardgleckman.com , Aug. 30, 2023. “ The Biggest Barrier to New Anti-Alzheimer’s Drugs May Be Cost, Not Medicare Rules ,” by Howard Gleckman, howardgleckman.com , June 14, 2023. “ The War Over Whether Medicare Should Pay for new Anti-Alzheimer’s Drugs ,” by Howard Gleckman, howardgleckman.com , May 17, 2023. “ The U.S. Predicts Big Increases in Skilled Nursing and Long-Term Care Costs ,” by Howard Gleckman, howardgleckman.com , April 14, 2023. “ Should You Enroll in a Medicare Advantage Plan? ” by Howard Gleckman, howardgleckman.com , Nov. 1, 2022. Government and Policy “ CMS’ New Transparency Rule Can Help ‘Weed Out a Few Bad Actors’ but Won’t Impact Deals Much, Other Factors at Play ,” by Shelby Grebbin, skillednursingnews.com , Dec. 6, 2023. “ Forbes’ Gleckman: Biden’s PE Ownership Scrutiny Is ‘Two Beats Behind,’” by Amy Stulick, skillednursingnews.com , April 28, 2022. “ Who Really Owns Nursing Homes, and How the Feds Are About to Learn More ,” by Howard Gleckman, howardgleckman.com , Nov. 27, 2023. “ Should State Long-Term Care Insurance Funds Invest in Stocks? ” by Howard Gleckman, howardgleckman.com , June 22, 2023. Caregivers “ Forget National Caregivers Month. Think About What Family Caregivers Need ,” by Howard Gleckman, howardgleckman.com , Nov. 7, 2023. “ For the First Time, Traditional Medicare Will Pay to Support Family Caregivers ,” by Howard Gleckman, howardgleckman.com , Aug. 23, 2023. Other Lotsa Helping Hands Medicare.gov Five-Star Quality Rating System Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.